I bought some more today (prior to the US market open in Germany) for an equivalent of 9.5 USc/share. Just checked again after a couple of hours and am positively surprised to be 30% in the money (at least on this last purchase).
Good things are heading our way, I am sure.
@Buildit,my guess is that the reason for this increase is the general uptrend of Biotechs in the vaccine business die to the new omikron variant of the virus.